{
  "id": 10453268,
  "title": "Kenya to manufacture new once-monthly HIV prevention pill: Key things to know about this deal",
  "url": "https://urgent.news/2026/09/28/kenya-to-manufacture-new-once-monthly-hiv-prevention-pill-key-things",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-28T13:28:32.000Z",
  "source": {
    "name": "People Daily Kenya",
    "slug": "people-daily-kenya",
    "url": "https://peopledaily.digital/insights/kenya-to-manufacture-new-once-monthly-hiv-prevention-pill-key-things-to-know-about-this-deal"
  },
  "original_language": "en",
  "account": null,
  "summary": "Kenya is set to become one of the first African countries preparing to manufacture a new HIV prevention medicine that could allow people at risk of infection to take one pill a month instead of taking a tablet every day. The medicine, known as alimatravir, or MK-8527, is being developed by pharmaceutical giant Merck, known […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Capital FM Kenya",
        "title": "Kenya among three African countries licensed to manufacture new HIV prevention pill",
        "url": "https://urgent.news/2026/09/28/kenya-among-three-african-countries-licensed-to-manufacture-new-hiv",
        "published": "2026-09-28T14:40:27.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}